These vaccines that have been preliminarily proven effective in animal experiments include a tumor-derived autophagome (Dribble) vaccine conjugated with mycobacterial HSP70407–426 (M2) peptide, soluble form of B, and T lymphocyte attenuator (sBTLA) in combination with HSP70 vaccine where recombinant adeno-associated viral (AAV) vectors served as the gene delivery, DCs pulsed with recombinant fusion protein of CEA576–669 and HSP70-like protein 1 (HSP70L1), and DCs pulsed with tumor cell lysate which was pulsed with M2 peptide and OK-432 [185,186,187,188,189]. The gene discussed is HSPA1A; the disease is neoplasm.